Meadox Vanguard

In 1995, Meadox (later acquired by Boston Scientific) approached NameStormers about naming a new aortic endograft for the treatment of abdominal aortic aneurysms. Since the patients that would be receiving the graft would be higher-risk, and there was no other endograft like it on the market, Meadox needed a name that conveyed strength, innovation, and trust. 

For patients, predominantly the elderly, in vulnerable health situations, it was important to Meadox that the name provide reassurance of excellent care and a best-in-class graft. Vanguard was chosen because of its meaning (“at the forefront of the action” or “troops moving at the head of the army”) and because of the way that the word looked and felt. Even if you didn’t know the meaning of vanguard, the root “guard” relayed strength, reliability, and protection. 

“Vanguard” became synonymous with Meadox’s innovative approach to treating abdominal aortic aneurysms, standing out as a name that reassured and inspired confidence. It effectively communicated the product’s cutting-edge capabilities and reliability, establishing it as a trusted solution in a highly specialized and critical medical field.